Metastatic Colorectal Cancers Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03007407Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on ChemotherapyTreatment
NCT03122509A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal CancerTreatment
NCT03435107Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal CancerTreatment